Personalized cell therapy takes on advanced melanoma in major trial
NCT ID NCT06743126
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests a one-time cell therapy called IMA203 for people with advanced melanoma that has not responded to prior treatment. IMA203 is made from a patient's own immune cells and is designed to target cancer cells. The study compares IMA203 to standard treatments like nivolumab plus relatlimab or lifileucel. About 360 participants will be enrolled to see if IMA203 improves survival and tumor shrinkage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IMA203 (anzutresgene autoleucel), a personalized cell therapy made from the patient's own immune cells
- What this could lead to
- If successful, this could offer a new, one-time cell therapy option for people with advanced melanoma that has stopped responding to standard treatments.
- What could go wrong
- This is an early Phase 3 trial, so results are not guaranteed. Cell therapies can cause serious side effects, and the treatment may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Assistance Publique Hopitaux De Paris, Hôpital Saint Louis
NOT_YET_RECRUITINGParis, 75010, France
-
Atlantic Health System/Morristown Medical Center
RECRUITINGMorristown, New Jersey, 07960, United States
-
Avera Cancer Institute
RECRUITINGSioux Falls, South Dakota, 57105, United States
-
BC Cancer - Vancouver
ACTIVE_NOT_RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
-
Baylor University
RECRUITINGDallas, Texas, 75246, United States
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
-
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
NOT_YET_RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Centre Hospitalier Universitaire De Lille
NOT_YET_RECRUITINGLille, 59000, France
-
Charite Universitaetsmedizin Berlin KöR
RECRUITINGBerlin, 12203, Germany
-
City of Hope National Medical Center
RECRUITINGDuarte, California, 91010, United States
-
Cleveland Clinic, Taussig Cancer Institute
RECRUITINGCleveland, Ohio, 44195, United States
-
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
NOT_YET_RECRUITINGRotterdam, 3015 GD, Netherlands
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
-
Goethe University Frankfurt
RECRUITINGFrankfurt am Main, 60590, Germany
-
Greater Glasgow and Clyde NHS, Beatson West of Scotland Cancer Center
NOT_YET_RECRUITINGGlasgow, G12 0YN, United Kingdom
-
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital
RECRUITINGLondon, SE1 9RT, United Kingdom
-
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
NOT_YET_RECRUITINGAmsterdam, 1066 CX, Netherlands
-
Honor Health Research Institute
RECRUITINGScottsdale, Arizona, 85258, United States
-
Huntsman Cancer Institute, University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Institut Gustave Roussy
NOT_YET_RECRUITINGVillejuif, 94800, France
-
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Lehigh Valley Topper Cancer Institute
ACTIVE_NOT_RECRUITINGAllentown, Pennsylvania, 18103, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic
RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic
ACTIVE_NOT_RECRUITINGRochester, Minnesota, 55905, United States
-
Mayo Clinic Florida
ACTIVE_NOT_RECRUITINGJacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
NOT_YET_RECRUITINGOxford, OX3 7LE, United Kingdom
-
Providence Cancer Institute Franz Clinic
RECRUITINGPortland, Oregon, 97213, United States
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Stanford Cancer Center
RECRUITINGStanford, California, 94305, United States
-
Technische Universitaet Dresden
RECRUITINGDresden, 01307, Germany
-
The Christie NHS Foundation Trust
NOT_YET_RECRUITINGManchester, M20 4GJ, United Kingdom
-
The Royal Marsden NHS Foundation Trust
NOT_YET_RECRUITINGLondon, SW3 6JJ, United Kingdom
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Thomas Jeffersion University, Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
UC San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
-
UCLA Hematology/Oncology
RECRUITINGLos Angeles, California, 90024, United States
-
UCSF Helen Diller Family Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94143, United States
-
UNC Hospitals, The University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Universitaet Leipzig
RECRUITINGLeipzig, 04103, Germany
-
Universitaetsklinikum Bonn AöR
NOT_YET_RECRUITINGBonn, 53127, Germany
-
Universitaetsklinikum Erlangen AöR
RECRUITINGErlangen, 91054, Germany
-
Universitaetsklinikum Essen AöR
RECRUITINGEssen, 45147, Germany
-
Universitaetsklinikum Heidelberg AöR
RECRUITINGHeidelberg, 69120, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
RECRUITINGMainz, 55131, Germany
-
Universitair Medisch Centrum Groningen
NOT_YET_RECRUITINGGroningen, 9713 GZ, Netherlands
-
Universitatsklinikum Koeln
RECRUITINGCologne, Northrhine-W Estphalia, 50937, Germany
-
University Health Network, Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
University Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, 20246, Germany
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
-
University of Colorado, Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
-
University of MD Greenebaum Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21201, United States
-
University of Miami - Sylvester Comprehensive Cancer Cente
RECRUITINGMiami, Florida, 33136, United States
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68198, United States
-
University of Pennsylvania, Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Rochester
RECRUITINGRochester, New York, 14642, United States
-
University of Southampton NHS Foundation Trust, Southampton General Hospital
NOT_YET_RECRUITINGSouthampton, SO16 6YD, United Kingdom
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23219, United States
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- E-Learning could sharpen Doctors' eye for skin cancer
- Can a new drug tame advanced solid tumors?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Could a Two-Drug combo reawaken the immune system against resistant cancers?
- Could starting immunotherapy earlier improve outcomes for High-Risk melanoma?